.Merck beats profits expectations, increases sales outlook on strong demand for best medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Forecasts as Keytruda Sales Surge BloombergMerck Supply: Pharma Titan Posts Sturdy Outcomes, Yet Expectation Falls Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats profit and sales expectations surrounded by Keytruda strong point, yet offers combined full-year overview MarketWatch.